+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation Biomanufacturing Market - Global Forecast 2026-2032- Product Image
Next-Generation Biomanufacturing Market - Global Forecast 2026-2032- Product Image
New

Next-Generation Biomanufacturing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5925154
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Next-generation biomanufacturing is fundamentally reshaping how leading organizations produce and commercialize complex biologics. Industry executives are now navigating unprecedented change, with rapid technical innovation and evolving regulations demanding agile, informed decisions.

Market Snapshot: Next-Generation Biomanufacturing Market

The global next-generation biomanufacturing market advanced from USD 466.22 million in 2025 to USD 594.43 million in 2026. Projected to expand at a 28.00% CAGR, total market value is expected to reach USD 2.62 billion by 2032. Growth is fueled by the convergence of digital process enablement, new regulatory frameworks, and increasing demand for advanced biologics in diverse therapeutic areas. Senior decision-makers are leveraging these shifts to expedite commercialization and enhance operational flexibility across multiple segments of biomanufacturing.

Scope & Segmentation

This report offers senior leaders a strategic overview of the next-generation biomanufacturing sector, structured to reflect critical segments and geographic trends relevant for high-stakes decision-making:

  • Product Types: Includes cell and gene therapies, monoclonal antibodies, recombinant proteins, enzymes for both diagnostic and industrial purposes, and a spectrum of vaccines such as mRNA, viral vector, subunit, and live attenuated.
  • Technology Choices: Covers modular facilities, cell-free systems, continuous bioprocessing, single-use bioreactors and components, advanced inline monitoring, perfusion, and integrated process analytics.
  • Process Stages: Addresses upstream mechanisms like cell culture and media preparation, downstream processes such as chromatography and purification, and formulation steps ranging from fill-and-finish to final packaging.
  • End Users: Serves academic and research institutions, biotech enterprises, contract manufacturing organizations, and pharmaceutical firms engaged at different scales of biologics production.
  • Scales of Operation: Encompasses clinical, pilot, and full commercial manufacturing environments to support both product development and large-scale rollout.
  • Cell Lines: Analyzes the usage of mammalian (e.g., CHO), bacterial (e.g., E. coli), and yeast systems (Pichia pastoris, Saccharomyces cerevisiae) for adaptable biomanufacturing applications.
  • Process Modes: Discusses batch, continuous, fed-batch, and perfusion production strategies to optimize yield and quality.
  • Regions: Highlights expansion opportunities and risk considerations in North America, EMEA, and Asia-Pacific, each presenting unique regulatory and operational priorities.

Platform Therapies and Technology Use

Adoption of modular facility models, digital controls, and advanced analytics underpins efficient development and commercial launch of next-generation biological products. Tailored approaches address the unique demands of cell and gene therapies, recombinant proteins, and new vaccine modalities. These capabilities support flexible adjustment in operational scale, process quality, and compliance requirements, ensuring readiness for shifting market and stakeholder expectations.

Key Takeaways for Senior Decision-Makers

  • Integrating advanced digital technologies enhances visibility and speeds response to deviations, fostering dependable manufacturing outcomes.
  • Continuous processing and use of single-use components facilitate reduced changeover and lower capital expenditure, accommodating both novel therapies and mature biologics.
  • Active partnerships among technology suppliers, contract manufacturers, and end users catalyze innovation and smooth adaptation to changing regulations.
  • Building resilient supply chains requires careful supplier diversification coupled with strategic inventory planning and robust collaboration with third-party manufacturers.
  • Expanding sustainability efforts—such as circular economy practices for disposables and energy-conscious facility management—strengthens compliance and stakeholder relationships.

Tariff Impact on Supply Chain Strategy

Ongoing tariff developments through 2025 have reshaped the global supplier landscape for biomanufacturing. Companies are intensifying regional supplier diversification and localizing sourcing for high-risk components to mitigate geopolitical exposure. Implementation of stronger contracts, updated supplier validation procedures, and detailed contingency planning now form the backbone of contemporary procurement and supply chain strategies in the sector.

Methodology & Data Sources

The findings of this report are anchored in a comprehensive research methodology combining primary interviews with subject matter experts, systematic literature reviews, and forward-looking scenario analysis. Each section has undergone a thorough peer review process, with insights grounded in documented industry best practices for next-generation biomanufacturing.

Why This Report Matters

  • Delivers actionable segmentation frameworks to align technology investments and operating models with current and future therapeutic demands.
  • Enables benchmarking of facility design, supplier selection, and adoption of digital tools against recognized industry standards for enhanced competitiveness.
  • Empowers strategic risk management, supply chain optimization, and partnership formation amid complex regulatory and tariff trends impacting the biomanufacturing landscape.

Conclusion

For sustainable competitiveness, integrated approaches combining platform innovation, supply chain diversification, and digital transformation are now essential. With these insights, senior leaders can confidently navigate evolving market requirements while upholding compliance and operational agility.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Next-Generation Biomanufacturing Market, by Product Type
8.1. Cell And Gene Therapies
8.1.1. Car-T Therapies
8.1.2. Cell Therapies
8.1.3. Gene Editing Therapies
8.2. Enzymes
8.2.1. Diagnostic Enzymes
8.2.2. Industrial Enzymes
8.3. Monoclonal Antibodies
8.3.1. Autoimmune
8.3.2. Infectious Diseases
8.3.3. Oncology
8.4. Recombinant Proteins
8.4.1. Cytokines
8.4.2. Growth Factors
8.4.3. Hormones
8.5. Vaccines
8.5.1. Live Attenuated Vaccines
8.5.2. Mrna Vaccines
8.5.3. Subunit Vaccines
8.5.4. Viral Vector Vaccines
9. Next-Generation Biomanufacturing Market, by Technology
9.1. Cell-Free Systems
9.1.1. Cell-Free Expression Kits
9.1.2. Cell-Free Synthesis Platforms
9.2. Continuous Bioprocessing
9.2.1. Continuous Chromatography
9.2.2. Inline Monitoring Systems
9.2.3. Perfusion Systems
9.3. Modular Facilities
9.3.1. Prefabricated Modules
9.3.2. Skid-Mounted Systems
9.4. Single-Use Systems
9.4.1. Single-Use Bags
9.4.2. Single-Use Bioreactors
9.4.3. Single-Use Tubing And Connectors
10. Next-Generation Biomanufacturing Market, by Process Stage
10.1. Downstream Processing
10.1.1. Chromatography
10.1.2. Filtration
10.1.3. Purification
10.2. Formulation
10.2.1. Fill And Finish
10.2.2. Lyophilization
10.2.3. Packaging
10.3. Upstream Processing
10.3.1. Bioreactor Operation
10.3.2. Cell Culture
10.3.3. Media Preparation
11. Next-Generation Biomanufacturing Market, by Operation Scale
11.1. Clinical Scale
11.2. Commercial Scale
11.3. Pilot Scale
12. Next-Generation Biomanufacturing Market, by Cell Line
12.1. Cho Cell
12.1.1. Cho-DG44
12.1.2. Cho-K1
12.2. E. Coli
12.2.1. Bl21
12.2.2. K12
12.3. Yeast
12.3.1. Pichia Pastoris
12.3.2. Saccharomyces Cerevisiae
13. Next-Generation Biomanufacturing Market, by Process Mode
13.1. Batch
13.2. Continuous
13.3. Fed Batch
13.4. Perfusion
14. Next-Generation Biomanufacturing Market, by End User
14.1. Academic And Research Institutions
14.2. Biotech Companies
14.3. Contract Manufacturing Organizations
14.4. Pharmaceutical Companies
15. Next-Generation Biomanufacturing Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Next-Generation Biomanufacturing Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Next-Generation Biomanufacturing Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Next-Generation Biomanufacturing Market
19. China Next-Generation Biomanufacturing Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Agilent Technologies, Inc.
20.6. Amyris, Inc.
20.7. Applikon Biotechnology BV
20.8. bbi-biotech GmbH
20.9. Biofluidica, Inc.
20.10. Codexis, Inc.
20.11. Danaher Corporation
20.12. Eppendorf AG
20.13. ESCO Group
20.14. Eurofins Scientific SE
20.15. Evolva Holding SA
20.16. Evonik Industries AG
20.17. GEA Group AG
20.18. GENEWIZ, Inc. by Azenta Life Sciences
20.19. Genomatica, Inc.
20.20. Ginkgo Bioworks Holdings, Inc.
20.21. Hamilton Company
20.22. Illumina, Inc.
20.23. Koninklijke DSM N.V.
20.24. LanzaTech, Inc.
20.25. Macrogen Inc.
20.26. Merck KGaA
20.27. Novozymes A/S
20.28. Oxford Nanopore Technologies plc
20.29. PBS Biotech, Inc.
20.30. PerkinElmer Inc.
20.31. QIAGEN N.V.
20.32. Sartorius AG
20.33. Shanghai Bailun Biotechnology Co., Ltd.
20.34. Solaris Biotechnology Srl by DONALDSON ITALIA S.R.L.
20.35. Takara Bio Inc.
20.36. Thermo Fisher Scientific Inc.
20.37. ZETA GmbH
20.38. Zymergen Inc.
List of Figures
FIGURE 1. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GENE EDITING THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GENE EDITING THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GENE EDITING THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTIC ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTIC ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTIC ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MRNA VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MRNA VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VIRAL VECTOR VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VIRAL VECTOR VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE EXPRESSION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE EXPRESSION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE EXPRESSION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYNTHESIS PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYNTHESIS PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYNTHESIS PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INLINE MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INLINE MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INLINE MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PREFABRICATED MODULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PREFABRICATED MODULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PREFABRICATED MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SKID-MOUNTED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SKID-MOUNTED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SKID-MOUNTED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BAGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BAGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE TUBING AND CONNECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE TUBING AND CONNECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE TUBING AND CONNECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILL AND FINISH, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILL AND FINISH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILL AND FINISH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LYOPHILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LYOPHILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MEDIA PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MEDIA PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CLINICAL SCALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CLINICAL SCALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CLINICAL SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COMMERCIAL SCALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COMMERCIAL SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PILOT SCALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PILOT SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-DG44, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-DG44, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-DG44, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-K1, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-K1, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-K1, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BL21, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BL21, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BL21, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY K12, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY K12, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY K12, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PICHIA PASTORIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PICHIA PASTORIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PICHIA PASTORIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FED BATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FED BATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FED BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 223. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 224. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 226. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 227. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 228. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 229. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 230. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 232. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2032 (USD MILLION)
TABLE 233. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2032 (USD MILLION)
TABLE 234. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 235. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2032 (USD MILLION)
TABLE 236. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 237. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 238. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 239. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2032 (USD MILLION)
TABLE 240. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2032 (USD MILLION)
TABLE 241. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2032 (USD MILLION)
TABLE 242. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2032 (USD MILLION)
TABLE 243. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 244. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2032 (USD MILLION)
TABLE 245. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 249. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 251. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 252. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 253. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 255. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2032 (USD MILLION)
TABLE 256. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2032 (USD MILLION)
TABLE 257. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 258. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2032 (USD MILLION)
TABLE 259. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 260. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 261. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 262. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2032 (USD MILLION)
TABLE 263. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2032 (USD MILLION)
TABLE 264. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2032 (USD MILLION)
TABLE 265. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2032 (USD MILLION)
TABLE 266. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 267. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2032 (USD MILLION)
TABLE 268. NORTH AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 272. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 273. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 274. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 275. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 276. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 277. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 278. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2032 (USD MILLION)
TABLE 279. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2032 (USD MILLION)
TABLE 280. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2032 (USD MILLION)
TABLE 281. LATIN AMERICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCE

Companies Mentioned

The key companies profiled in this Next-Generation Biomanufacturing market report include:
  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Applikon Biotechnology BV
  • bbi-biotech GmbH
  • Biofluidica, Inc.
  • Codexis, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • ESCO Group
  • Eurofins Scientific SE
  • Evolva Holding SA
  • Evonik Industries AG
  • GEA Group AG
  • GENEWIZ, Inc. by Azenta Life Sciences
  • Genomatica, Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Hamilton Company
  • Illumina, Inc.
  • Koninklijke DSM N.V.
  • LanzaTech, Inc.
  • Macrogen Inc.
  • Merck KGaA
  • Novozymes A/S
  • Oxford Nanopore Technologies plc
  • PBS Biotech, Inc.
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Sartorius AG
  • Shanghai Bailun Biotechnology Co., Ltd.
  • Solaris Biotechnology Srl by DONALDSON ITALIA S.R.L.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • ZETA GmbH
  • Zymergen Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 594.43 Million
Forecasted Market Value ( USD ) by 2032 $ 2620 Million
Compound Annual Growth Rate28.0%
Regions CoveredGlobal
No. of Companies Mentioned35

Related Topics

Related Reports

Biomanufacturing Viral Detection & Quantification Market - Global Forecast 2026-2032 - Product Image

Biomanufacturing Viral Detection & Quantification Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Digital Biomanufacturing Market - Global Forecast 2026-2032 - Product Image

Digital Biomanufacturing Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
The Global Synthetic Biology & Biomanufacturing Market 2026-2036 - Product Image

The Global Synthetic Biology & Biomanufacturing Market 2026-2036

  • Report
  • 1135 Pages
  • Global
Biomanufacturing Market - Global Strategic Business Report - Product Image

Biomanufacturing Market - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
The Global Industrial Biomanufacturing Market 2026-2036 - Product Image

The Global Industrial Biomanufacturing Market 2026-2036

  • Report
  • 1316 Pages
  • Global
From

About the Next Generation Biomanufacturing Market

The Next Generation Biomanufacturing market is a subset of the biotechnology industry that focuses on the development of advanced manufacturing technologies for the production of biopharmaceuticals. This includes the use of cell and gene therapies, as well as the development of novel bioprocessing techniques. These technologies are used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. The Next Generation Biomanufacturing market is driven by the increasing demand for biopharmaceuticals, as well as the need to reduce the cost of production. This has led to the development of new technologies such as single-use bioreactors, automated bioprocessing systems, and advanced analytics. These technologies are being used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. Some of the companies in the Next Generation Biomanufacturing market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Lonza, and Sartorius AG. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.